PAPA & BARKLEY RELEAF - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Serial Number
88977778
Word Mark
PAPA & BARKLEY RELEAF
Status
661 - Response After Non-Final Action - Entered
Status Date
2021-06-05
Filing Date
2019-02-25
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
050702, 241714, 260102 - Clusters and sheaves of other grains, including stalks of grains. Punctuation marks, including commas(,), question marks(?), exclamation points(!�), ampersands(&), at symbols(@), and hyphens(-). Plain single line circles.
Attorney Name
Law Office Assigned Location Code
O30
Employee Name
SALES, HEATHER ALISON
Statements
Indication of Colors claimed
The color(s) blue is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized wording "PAPA & BARKLEY RELEAF" in blue. In between the words "PAPA" and "BARKLEY" is the ampersand sitting inside a blue outline of a circle with a narrow blue leaf running through the ampersand. The wording "RELEAF" sits below the wording "PAPA". The white in the drawing is for background areas only and is not a feature of the mark.
Goods and Services
Inedible non-medicated essential oils, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Cosmetics, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Cosmetics, non-medicated body oils and non-medicated body ointments, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Cosmetics, non-medicated body oils and non-medicated body ointments in drop form, capsule form, and liquid form, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Non-medicated body soaks, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Electronic cigarette liquid (e-liquid) comprised of essential oils, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act
Goods and Services
Mentholated ointment for medical use, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin oils, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical analgesics, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Analgesic balm, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin creams and lotions, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated skin care preparations, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all the foregoing for the relief of pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Herbal tinctures for medical purposes, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all of the foregoing containing only naturally-occurring levels of CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated oral spray for pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in connection with pain, muscle tension, muscle spasms, and gastrointestinal illness, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Muscle soaks, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act
Pseudo Mark
PAPA AND BARKLEY RELIEF
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-03-15
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Thomas F. Zuber
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Parent | 88314433 |
Continuity Child | 88983068 |
Trademark Events
Event Date | Event Description |
2019-02-28 | NEW APPLICATION ENTERED IN TRAM |
2019-03-15 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-03-21 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2019-05-06 | ASSIGNED TO EXAMINER |
2019-05-06 | ASSIGNED TO EXAMINER |
2019-10-28 | ASSIGNED TO EXAMINER |
2019-10-29 | NON-FINAL ACTION WRITTEN |
2019-10-29 | NON-FINAL ACTION E-MAILED |
2019-10-29 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-04-29 | TEAS REQUEST TO DIVIDE RECEIVED |
2020-04-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-05-04 | ASSIGNED TO LIE |
2020-04-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-05-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-05-11 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-04-29 | DIVISIONAL REQUEST RECEIVED |
2020-05-12 | DIVISIONAL PROCESSING COMPLETE |
2020-05-13 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2020-06-15 | FINAL REFUSAL WRITTEN |
2020-06-15 | FINAL REFUSAL E-MAILED |
2020-06-15 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2020-12-07 | NON-FINAL ACTION WRITTEN |
2020-12-07 | NON-FINAL ACTION E-MAILED |
2020-12-07 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-03-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-03-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-03-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-06-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-06-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-06-05 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-09-24 | TEAS REQUEST TO DIVIDE RECEIVED |
2021-09-24 | DIVISIONAL REQUEST RECEIVED |
2021-09-29 | DIVISIONAL PROCESSING COMPLETE |